Delayed application of MK-801 attenuates development of morphine tolerance in rats

Brain Res. 1991 Aug 30;558(1):163-5. doi: 10.1016/0006-8993(91)90736-f.

Abstract

To investigate the possible involvement of enduring or delayed changes at the N-methyl-D-aspartic acid (NMDA) receptor in the mechanisms of morphine tolerance, rats were treated with the specific NMDA receptor antagonist, MK-801 (0.15 mg/kg) 2 h after morphine injection (20 mg/kg) during a 4-day induction period of tolerance. On the fifth day rats were injected only with morphine (15 mg/kg), and analgesia was assessed using the hot-plate test. Morphine tolerance was significantly reduced by MK-801. These findings suggest that long-lasting or delayed changes at the NMDA receptor underlie the development of morphine tolerance. Moreover, because MK-801 was delivered 2 h after morphine and therefore could not serve as a cue for morphine administration, these findings indicate that the attenuating effect of MK-801 on the development of morphine tolerance is not attributable to state-dependent learning.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Analysis of Variance
  • Animals
  • Dizocilpine Maleate / pharmacology*
  • Drug Tolerance
  • Male
  • Morphine / pharmacology*
  • Rats
  • Rats, Inbred Strains
  • Time Factors

Substances

  • Dizocilpine Maleate
  • Morphine